Real-time enrollment status for this adenoid cystic carcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:26 PM UTC
| NCT Number | NCT06118086 |
| Recruiting Status | Recruiting |
| Condition | Adenoid Cystic Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 125 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Remix Therapeutics |
| Last Updated on CT.gov | June 24, 2026 (Jun 24, 2026) |
As of October 12, 2026: Clinical trial NCT06118086 is currently recruiting participants. This phase1 study for adenoid cystic carcinoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Remix Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06118086 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06118086 was last updated Jun 24, 2026 (June 24, 2026). HelloStudys verifies this status automatically.